Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 5786  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
  NAVIGATE Here 
 ::   Next article
 ::   Previous article
 ::   Table of Contents

 RESOURCE Links
 ::   Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::   Citation Manager
 ::   Access Statistics
 ::   Reader Comments
 ::   Email Alert *
 ::   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4543    
    Printed106    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal


 

 ARTICLE
Year : 1977  |  Volume : 23  |  Issue : 4  |  Page : 147-155

Clinical experience with metolazone-a new diuretic­ in cases of edema and ascites due to hepatic cirrhosis, C.C.F.,, and malnutrition


1 Clinical Pharmacology Unit, K.E.M. Hospital and Seth G. S. Medical College, Parel, Bombay 400 012, India
2 Department of Pharmacology and Medicine, K.E.M. Hospital and Seth G. S. Medical College, Parel, Bombay 400 012, India
3 Clinical Drug Trial Unit, (CSIR), K.E.M. Hospital and Seth G. S. Medical College, Parel, Bombay 400 012, India
4 Tata Blood Bank, Bombay, India
5 J.J. Hospital and the Department o f Statistics, University of Bombay, Bombay., India

Correspondence Address:
U K Sheth
Clinical Pharmacology Unit, K.E.M. Hospital and Seth G. S. Medical College, Parel, Bombay 400 012
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 615260

Rights and PermissionsRights and Permissions

Metolazone [2-methyl-3-(0-tolyl)-6-sulpharnyl-7-chloro-1, 2, 3, 4­tetra hydro-4-quinazolinone] is recently introduced as a new orally acting diuretic. It is structurally related to sulfonamides and benzo­thiazidines. 41 male patients suffering from generalised edema due to various causes including 7 cases of congestive cardiac failure, 6 cases of malnutrition and 28 cases of hepatic cirrhosis were treated with metolazone given orally in a dose varying from 5 to 60 mg per day. The optimum effective dose was found to be 5 mg per day. 36 cases responded well with a loss of body weight ranging from 2.5 kg. to 12 kg. There was a significant increase in the urine volume and the urinary sodium, potassium and chloride excretion. Saluretic response was marked. Urinary sodium increased from 8-20 mEq/ day to 100 to 120 mEq in 24 hours. No serious side effects were observed during this study. Hypokalemia and hyponatremia occurred on increase of the dose. Occasionally leg cramps and abdominal distress were observed. Metolazone was found to be an effective orally active diuretic in a dose of 5 to 10 , mg/day.






[FULL TEXT] [PDF Not available]*


        
Print this article     Email this article

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow